Researchers looked at the nine people who had vision problems while using the drugs and is one of several that have ...

SoftBank Group posted a surprise quarterly loss Wednesday and the Japanese company's revenue also missed analysts' estimates.

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

There’s no direct link between vision loss and taking the weight loss and diabetes drugs such as Ozempic, Wegovy, Mounjaro, ...

A study finds GLP-1 weight-loss drugs may pose vision risks, revealing an unexpected medical irony. A paradoxical insight: ...

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

Japan's SoftBank Group booked a surprise $2.4 billion quarterly loss on Wednesday, hit by a decline in the value of ...

Japanese technology investor SoftBank Group booked a surprising net loss of 369.2 billion yen ($2.4 billion) in the ...

A small number of patients using GLP-1 weight loss medications have experienced vision loss, although researchers have not ...

SoftBank reported a net loss of nearly $2.4 billion for its fiscal third quarter, with another quarter in the red for its ...

SoftBank Group Corp. swung to losses for the December quarter due to a drop in the value of the Vision Fund’s public holdings ...